ArticleBiological trace element research2026
Selenium-Related Genes Modulate Susceptibility to Parkinson's Disease Via Combination and SNCA-Interactive Effects Rather than Independent Effects: A Case-Control Study.
Article in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Oxidative stress is widely recognized as a key contributor to the pathogenesis of Parkinson's disease (PD), yet the contribution of genetic variation in selenium-related pathways remains incompletely understood. In this study, we investigated whether selenium-related genetic variations contribute to PD susceptibility in a Han Chinese population comprising 527 sporadic PD patients and 499 controls. Nine polymorphisms in SNCA, EEFSEC, GPX1, GPX4, TXNRD2, SELENOP, SELENOW, SOD2, and CAT were genotyped using improved multiplex ligation detection reaction. Logistic regression analyses adjusted for age and sex were performed to evaluate individual associations. Combined genotype and interaction analyses were conducted to investigate combination effects among the variants and their interactions with SNCA. Among the investigated variants, only SNCA rs356203 was significantly associated with PD after Bonferroni correction. Although no significant association was observed individually for the remaining variants, a genotype combination involving EEFSEC, GPX1, GPX4, and TXNRD2 was significantly associated with reduced PD susceptibility. Interaction analyses using the recessive model revealed no significant interactions between the selenium-related gene variants and SNCA rs356203 in the total population. However, significant sex-specific interactions were observed: EEFSEC with SNCA in males, and TXNRD2 with SNCA in females. These findings confirm the association between SNCA rs356203 and PD risk and suggest that selenium-related genes may modulate PD susceptibility primarily through combined rather than independent effects. Our study also offers novel genetic insights linking SNCA to selenium-related antioxidant pathways in sporadic PD.
Indexed as
Identifiers
42658426What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.